Works matching IS 09546820 AND DT 2012 AND VI 271 AND IP 4

Results: 12

Adipose zinc-[alpha]2-glycoprotein is a catabolic marker in cancer and noncancerous states.

Published in:

2012

By:

Rydén M;
Agustsson T;
Andersson J;
Bolinder J;
Toft E;
Arner P

Publication type:

Journal Article

Prostasomes are mediators of intercellular communication: from basic research to clinical implications.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 400, doi. 10.1111/j.1365-2796.2011.02487.x

By:

Ronquist, G.

Publication type:

Article

Resolving the variable genome and epigenome in human disease.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 379, doi. 10.1111/j.1365-2796.2011.02508.x

By:

Knight, J. C.

Publication type:

Article

Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 318, doi. 10.1111/j.1365-2796.2012.02527.x

By:

Hall, P.

Publication type:

Article

Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC).

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 366, doi. 10.1111/j.1365-2796.2011.02509.x

By:

Bolton, K. L.;
Ganda, C.;
Berchuck, A.;
Pharaoh, P. D. P.;
Gayther, S. A.

Publication type:

Article

Genetic variants associated with predisposition to prostate cancer and potential clinical implications.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 353, doi. 10.1111/j.1365-2796.2012.02511.x

By:

Goh, C. L.;
Schumacher, F. R.;
Easton, D.;
Muir, K.;
Henderson, B.;
Kote-Jarai, Z.;
Eeles, R. A.

Publication type:

Article

Utility of Genome-Wide Association Study findings: prostate cancer as a translational research paradigm.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 344, doi. 10.1111/j.1365-2796.2012.02522.x

By:

Turner, A. R.;
Kader, A. K.;
Xu, J.

Publication type:

Article

Adipose zinc-α2-glycoprotein is a catabolic marker in cancer and noncancerous states.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 414, doi. 10.1111/j.1365-2796.2011.02441.x

By:

Rydén, M.;
Agustsson, T.;
Andersson, J.;
Bolinder, J.;
Toft, E.;
Arner, P.

Publication type:

Article

Symposium: COGS International Scientific Seminar.

Published in:: 2012
Publication type:: Table of Contents

Prevention of breast cancer in the context of a national breast screening programme.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 321, doi. 10.1111/j.1365-2796.2012.02525.x

By:

Howell, A.;
Astley, S.;
Warwick, J.;
Stavrinos, P.;
Sahin, S.;
Ingham, S.;
McBurney, H.;
Eckersley, B.;
Harvie, M.;
Wilson, M.;
Beetles, U.;
Warren, R.;
Hufton, A.;
Sergeant, J.;
Newman, W.;
Buchan, I.;
Cuzick, J.;
Evans, D. G.

Publication type:

Article

Progress against cancer (1971-2011): how far have we come?

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 392, doi. 10.1111/j.1365-2796.2011.02462.x

By:

Tiwari, A. K.;
Roy, H. K.

Publication type:

Article

Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers.

Published in:

Journal of Internal Medicine, 2012, v. 271, n. 4, p. 331, doi. 10.1111/j.1365-2796.2011.02502.x

By:

Barnes, D. R.;
Antoniou, A. C.

Publication type:

Article